<table id="_Refinv-a36608d5-fa95-44ab-bf80-8e4f9ebb" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4. Established and Other Potentially Significant Drug Interactions </caption>
<col width="40%"></col>
<col width="24%"></col>
<col width="51%"></col>
<tfoot>
<tr>
<td align="left" colspan="3" stylecode="Botrule" valign="top">↓= Decreased (induces lamotrigine glucuronidation).</td>
</tr>
<tr>
<td align="left" colspan="3" stylecode="Botrule" valign="top">↑= Increased (inhibits lamotrigine glucuronidation).</td>
</tr>
<tr>
<td align="left" colspan="3" stylecode="Botrule" valign="top">? = Conflicting data.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" stylecode="Toprule ">
<paragraph> C<content stylecode="bold">oncomitant Drug</content>
</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>
<content stylecode="bold">Effect on Concentration of Lamotrigine or Concomitant Drug</content>
</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>
<content stylecode="bold">Clinical Comment</content>
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel </paragraph>
</td>
<td>
<paragraph> ↓ lamotrigine ↓ levonorgestrel</paragraph>
</td>
<td>
<paragraph> Decreased lamotrigine levels approximately 50%.  Decrease in levonorgestrel component by 19%. </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Carbamazepine and Carbamazepine epoxide </paragraph>
</td>
<td>
<paragraph> ↓ lamotrigine ? CBZ epoxide</paragraph>
</td>
<td>
<paragraph> Addition of carbamazepine decreases lamotrigine concentration approximately 40%.  May increase carbamazepine epoxide levels. </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Phenobarbital/Primidone </paragraph>
</td>
<td>
<paragraph> ↓ lamotrigine</paragraph>
</td>
<td>
<paragraph> Decreased lamotrigine concentration approximately 40%. </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Phenytoin </paragraph>
</td>
<td>
<paragraph> ↓ lamotrigine</paragraph>
</td>
<td>
<paragraph> Decreased lamotrigine concentration approximately 40%. </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Rifampin </paragraph>
</td>
<td>
<paragraph> ↓ lamotrigine</paragraph>
</td>
<td>
<paragraph> Decreased lamotrigine AUC approximately 40%. </paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph> Valproate </paragraph>
</td>
<td stylecode="Botrule ">
<paragraph> ↑ lamotrigine ? valproate</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph> Increased lamotrigine concentrations slightly more than 2-fold.  Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients. </paragraph>
</td>
</tr>
</tbody>
</table>